oral glp-1 receptor agonists are generating a great deal of excitement as a potential inflection point in diabetes and obesity care. Amid the enthusiasm, however, a quieter and clinically important issue is 3 Takeaways from the Landmark

[47:36] Andrew Huberman Would Teva sell the patent

This combination appears to provide the strongest weight loss outcomes to date

All current evidence comes from animal studies and anecdotal reports

This is your complete, honest guide to GHK-Cu for hair growth in 2026 the mechanism, the clinical evidence, a realistic before-and-after timeline, and exactly how to use the I'm Fabulous Cosmetics GHK-Cu Organic Copper Peptide Serum for both scalp and skin

Retatrutide is a triple agonist in late-stage clinical development by Eli Lilly that activates three receptors at once (GLP-1, GIP, and glucagon)

The strategies shared here offer a practical guide to help you navigate this adjustment phase while keeping your weight loss goals on track